285 results
Page 9 of 15
S-4/A
EX-10.1
eygjm
1 Nov 18
Registration of securities issued in business combination transactions (amended)
5:32pm
S-4/A
EX-10.4
8oblv
1 Nov 18
Registration of securities issued in business combination transactions (amended)
5:32pm
S-4/A
EX-10.6
33ald81v0m76
1 Nov 18
Registration of securities issued in business combination transactions (amended)
5:32pm
S-4/A
EX-23.1
5ih2ka6pk6m16bl2ur1
1 Nov 18
Registration of securities issued in business combination transactions (amended)
5:32pm
S-4/A
EX-23.2
i8rl c78h
1 Nov 18
Registration of securities issued in business combination transactions (amended)
5:32pm
S-4/A
EX-23.3
zuo4w sz4
1 Nov 18
Registration of securities issued in business combination transactions (amended)
5:32pm
S-4/A
fqxnsh5
1 Nov 18
Registration of securities issued in business combination transactions (amended)
5:32pm
S-4/A
EX-10.45
s4ev f3e4opcpube8kp
1 Nov 18
Registration of securities issued in business combination transactions (amended)
5:32pm
8-K
EX-10.1
l6sr szm9
1 Nov 18
OvaScience and Millendo Therapeutics Provide Update on Merger Agreement and Financing
5:01pm
425
EX-10.1
x65l0lmlp 32
1 Nov 18
Business combination disclosure
5:00pm
S-8
EX-23.2
oj3irwr 5y
9 Aug 18
Registration of securities for employees
5:29pm
8-K
EX-2.1
ymh 5iuuc
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
8-K
EX-99.3
iiku01gf7yai3shr349
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
8-K
EX-3.1
7rv28fccn
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
425
EX-99.3
q884wtrjokl6iw7f90ce
9 Aug 18
Business combination disclosure
5:17pm
425
EX-3.1
tdo178bnb1frfl
9 Aug 18
Business combination disclosure
5:17pm
425
EX-2.1
kequbed
9 Aug 18
Business combination disclosure
5:17pm
8-K
s7p3irnp3vmft
26 Jun 18
Submission of Matters to a Vote of Security Holders
4:05pm